| Tag | Content |
|---|
EnhancerAtlas ID | HS095-21084 | Organism | Homo sapiens | Tissue/cell | HMEC | Coordinate | chr3:112496450-112497730 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_65196 | chr3:112495815-112498505 | NHEK |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH03I112773 | chr3 | 112492242 | 112499521 |
| Enhancer Sequence | GAGGCCCCTA AACCCATCCA AAGGTTTTCC CTGCCCCAGA ATAGACAGGC CCAAGAAGAG 60
AAGTTTACCC AATCTTGCCC ACCTATCTAA GTCCTGGACC CAATCACTCT GGCCTCTAAT 120
CTGTCTCTGA CTTTGACCCC CAGCTCTAAA AACTGCGCCA GATTCTTCAC TCAAAAACAT 180
TTATGGACCG TCTACTATGA AACAGGCATG CTCATCCTTC CTGGAGATAC AGTTGTGAAC 240
AAGACTCTGT CCCTATGGTC ATGGAGACTA TTGCCTAGTG AGAGACAGAA TTCAGTAAAA 300
AGGCAATTTC AGGAAGATGT GATAAATACT GGGATGGGGA AGTGGGAACA CTTAGGAGGG 360
CAGGGGGAGG CAGAGTGGGG CAGAAAAGAC TTCCTAGAGG AAGTGAGAGC TAAATCCAGA 420
TGCAAAGGAC CAGTAGAAGT GAACCAAGCA AAGAAGAGGT CTGTGGGTGT GGGCAGGGCA 480
GTGATTTTGG AGGAAGGAAT GGCAAGTTCA ATAGCTCAAA GGCTAAAGTG TAGGACAGGT 540
TCAAGGATCT GAAGATAATA TGGCTGAACC CAGAGGATCA TGGAGATGGG GCTGGAAATG 600
TGATGGCTTC CTAGATCGCT GTGTGAAAAA GTGTGTCCAC TGAGCATCCA GGCTTGGAAA 660
GAAAAAAAGA GTCATATCTG CCCTGGATTG TACTATAAAT TTCTTGAAAA TAAAAACTGT 720
GCTTATTCAT CTCTGCATCC CCAGTGCCTT GCAAAGTAGG CACAGTAATC TGTCAATAAA 780
CTTTCTTTCA AGGGTTCAAT TATTGCATGG GCTGGCTAAT AGCTTTTCTC TGCCTACAAT 840
TCCATATGAT GAATCACTGC AATGCCAGTG TTACGGTTGC ATAGTAAGTA TTAGAGCAAA 900
CGCTGGTCTC AGTCAGGTGG TAGTGGTATG TTAAGAATAC ACAGACTAAA ACAAAGATAT 960
TCTACATTCT ATACACTCAA TACATTCCAA GAGGGATTAA AGATATATCA GGATCCCCCC 1020
GCCACCACAT AGTACTACAC GTGGACACGT TTGATTTATA TGTCTCTTTT CTTCTTCAGA 1080
AGTTCTTTTT CTACCCCAAT TTGAAATGTT TTATAAAAAT TTTTTGAGGT TATTGCAGTT 1140
TTGTAGCAGT AATATGGTAA TGACTCACCT ATATTTCACA ATAAATTACT GTAAAAAGCA 1200
ACACCCACAA GCTTGCCAAT GAATTCCTCA GTTATCCTCT CTATGACCTA TGAAAATAGC 1260
AATGTTTTCT TTAATCATCA 1280
|
| |
|
|
|
